Norton Cancer Institute - Saint Matthews is a clinical research site located in Louisville, Kentucky, United States 40207.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Norton Cancer Institute - Saint Matthews has participated in 6 clinical trials with 4 currently active.
Therapeutic areas: Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Sponsors: ADC Therapeutics S.A., Atara Biotherapeutics, Gilead Sciences.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Norton Cancer Institute - Saint Matthews has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Norton Cancer Institute - Saint Matthews has 6 clinical trials on record, with 4 currently active. Their work covers Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Yes — Norton Cancer Institute - Saint Matthews holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.